- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01130675
Does Coffee Consumption Prevent or Shorten Postoperative Ileus After Colon Resection?
Does Coffee Consumption Prevent or Shorten Postoperative Ileus After Colon Resection? A Prospective Randomized Clinical Trial
Study Overview
Detailed Description
Recent evidence has shown that a multimodal rehabilitation program can accelerate recovery of GI function after colon resection. 8 A multicenter, randomized, placebo-controlled, double-blind, phase 3 trial demonstrated that Alvimopan, a peripherally acting mu-opioid receptor antagonist, appears to accelerate GI tract recovery by 1 day, and reduces postoperative ileus-related morbidity without compromising opioid analgesia. 9 Asao et al demonstrated that gum chewing can accelerate recovery of GI function, also by 1 day, after abdominal surgery. 10 Epidural anesthesia has been shown to shorten duration of POI, as well as improve pain control, decrease pulmonary complications, and quicken recovery times. However, it does not appear to reduce overall length of stay. 4 However, Neudecker et al. were unable to reproduce the results of previous trials evaluating the effect of thoracic epidural analgesia on duration of postoperative ileus following laparoscopic sigmoid resection. 11 Given conflicting data, no one single measure has been adopted for the prevention POI.
Recent evidence has shown that coffee may be a stimulant for the GI Tract. A small study of 16 healthy volunteers demonstrated that coffee appears to increase rectal tone thus implying an impact on defecation mechanics.12 Furthermore, several studies have demonstrated caffeinated coffee to be a stimulant of motor activity in the colon.13,14 Given its potential pro-motility properties in the GI tract, it seems reasonable to postulate that coffee, a commonly consumed product by the general public, may play a role in shortening and possibly preventing POI. This directly impacts overall patient satisfaction but will reduce length of stay and overall hospital costs.
Study Type
Enrollment (Actual)
Phase
- Phase 3
Contacts and Locations
Study Locations
-
-
Massachusetts
-
Worcester, Massachusetts, United States, 01605
- UMass Memorial Medical Center Memorial Campus
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Elective partial bowel resection with primary anastomosis for either cancer or benign disease.
- Laparoscopy or laparotomy
Exclusion Criteria:
- Total colectomy
- Colostomy
- Ileostomy
- Reversal of a stoma or synchronous resection
- Complete small or large bowel obstruction
Scheduled to receive other treatments or techniques to reduce ileus
1. epidural anesthetic tecniques
- Nasogastric tube for any length of timein the post-op period.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: standard care
|
|
Active Comparator: eight ounces of caffeinated coffee for breakfast and lunch
|
8 oz. of caffeinated cofee/breakfast&noon meal.
No intervention for 2nd arm.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Resolution of ileus
Time Frame: a mean difference of 24 hours to be significant
|
Measured by hours to first flatus or bowel movement and tolerance of solid food.
|
a mean difference of 24 hours to be significant
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- H-13493
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Postoperative Ileus
-
KU LeuvenUniversitaire Ziekenhuizen KU LeuvenRecruitingPostoperative IleusBelgium
-
West China HospitalCompletedPostoperative IleusChina
-
Hadassah Medical OrganizationCompleted
-
li xiongUnknown
-
Jinling Hospital, ChinaCompletedPostoperative IleusChina
-
Services Hospital, LahoreCompletedPostoperative IleusPakistan
-
KU LeuvenUniversitaire Ziekenhuizen KU LeuvenCompletedPostoperative IleusBelgium
-
Gabriele Baldini, MD, MSc, Assistant ProfessorCompleted
-
Benazir Bhutto Hospital, RawalpindiCompletedPostoperative Ileus.Pakistan
Clinical Trials on caffeinated coffee
-
Assistance Publique - Hôpitaux de ParisRecruitingADCY5-related DyskinesiaFrance
-
Massachusetts Eye and Ear InfirmaryCompleted
-
National Institute of Diabetes and Digestive and...Beth Israel Deaconess Medical Center; Harvard School of Public Health (HSPH)CompletedOverweightUnited States
-
University College CorkCompleted
-
Weill Medical College of Cornell UniversityNot yet recruitingTerbinafine Adverse ReactionUnited States
-
Harokopio UniversityBeth Israel Deaconess Medical CenterCompleted
-
University of MichiganWithdrawnBreast Reconstruction | Deep Inferior Epigastric Perforator | Microvascular Free Flap TransferUnited States
-
University of LausanneNestlé Research Center, Vers-chez-les-blanc, SwitzerlandCompletedHepatic SteatosisSwitzerland
-
University Hospital HeidelbergUnknown
-
University of California, San FranciscoRecruiting